developmental therapeutics Phase I study of the pan-fibroblast growth factor receptor (FGFR) inhibitor BAY 1163877 with expansion cohorts for subjects based on tumor FGFR mRNA expression levels

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 27; p. vi558
Main Authors Joerger, M., Soo, R., Cho, B.C., Mendivil, A. Navarro, Sayehli, C., Richly, H., Tai, D., Kim, D.-W., Wolf, J., Cassier, P., Ellinghaus, P., Hildebrandt, S., Behre, S., Helmbrecht, C., Kerpen, S., Zielinski, D., Ince, S., Rajagopalan, P., Ocker, M., Schuler, M.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2016
Online AccessGet full text
ISSN0923-7534
1569-8041
DOI10.1093/annonc/mdw435.10

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdw435.10